Back to Journals » Journal of Pain Research » Volume 18

Regarding “Enhancing Predictive Accuracy for Acute Herpetic Neuralgia Treatment: A Fresh Perspective on Pulsed Radiofrequency Therapy Research” [Response to Letter]

Authors Zhao C , Lu Z, Hua B, Yue J , Yang Q, Ni H, Yao M 

Received 14 November 2024

Accepted for publication 28 November 2024

Published 30 January 2025 Volume 2025:18 Pages 525—526

DOI https://doi.org/10.2147/JPR.S506601



Chengcheng Zhao,1,2 Ziwei Lu,1,2 Bohan Hua,1,2 Jiayu Yue,2 Qinru Yang,2 Huadong Ni,2 Ming Yao2

1Jiaxing University Master’s Degree Cultivation Base, Zhejiang Chinese Medical University, Jiaxing City, Zhejiang, People’s Republic of China; 2Department of Anesthesiology and Pain Research Center, the Affiliated Hospital of Jiaxing University, Jiaxing City, Zhejiang, People’s Republic of China

Correspondence: Ming Yao, Email [email protected]


View the original paper by Mr Zhao and colleagues

This is in response to the Letter to the Editor


Dear editor

In response to a recently published article, I am representing all authors to address the constructive comments and suggestions provided by Hong et al.1,2

Firstly, we acknowledge the variations in pain intensity and characteristics associated with shingles in different anatomical locations. Thus, it is more appropriate to categorize herpes zoster based on different sites. However, we have considered the significant differences in Current Perception Threshold (CPT) across sites, noting the prevalence of herpes zoster on the thoracic dorsal trunk. To mitigate heterogeneity, our initial exploration included only patients with thoracic dorsal herpes, as detailed in the methods section. Subsequently, we have factored in the site and nature of pain in our larger-scale studies, aligning with the recommendation by Hong et al.

Secondly, we recognize the validity of Hong et al’s concerns regarding variable covariance. We also accounted for this when screening the variables. We applied stepwise regression to minimize the effect of multiple covariances between variables, as described in the Results section. Of course, the suggestion by Hong et al to employ the Variance Inflation Factor (VIF) for assessing covariance between variables significantly contributed to our results. Therefore, we supplemented the VIF of multivariate logistic regression variables and the results show that no covariance problems were found among them (VIF<5). (Table 1)

Table 1 Variance Inflation Factor of Multivariate Logistic Regression Variables

Furthermore, we fully support Hong et al’s perspective on the collaborative multidisciplinary approach to managing patients with herpes zoster. Managing herpetic neuralgia poses a complex challenge that has long perplexed healthcare professionals. Particularly, managing patients with postherpetic neuralgia (PHN) presents unique difficulties. Therefore, the collaboration of pain physicians, dermatologists, neurologists, and psychologists is crucial to enhancing patient outcomes by leveraging their respective expertise. The proposal to establish a multidisciplinary management team is not only reasonable but also urgently required.

In conclusion, we express our gratitude to our readers for recognizing our research findings and offering valuable suggestions. We appreciate the opportunity to address and refine our study to ensure the accuracy of our results. By contributing to clinical decision-making for patients with herpes zoster neuralgia, we aim to facilitate more precise and personalized treatment approaches.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Zhao C, Lu Z, Hua B, et al. Predictive value of current perception threshold for prognosis of pulsed radiofrequency in patients with acute herpetic neuralgia. J Pain Res. 2024;17:3241–3253. doi:10.2147/JPR.S472535

2. Hong C, Ma Y, Yan C. Enhancing predictive accuracy for acute herpetic neuralgia treatment: a fresh perspective on pulsed radiofrequency therapy research [Letter]. J Pain Res. 2024;17:3841–3842. doi:10.2147/JPR.S500107

Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.